266 related articles for article (PubMed ID: 32120311)
1. Imaging manifestations of immune-related adverse effects in checkpoint inhibitor therapies: A primer for the radiologist.
Furtado VF; Melamud K; Hassan K; Rohatgi S; Buch K
Clin Imaging; 2020 Jul; 63():35-49. PubMed ID: 32120311
[TBL] [Abstract][Full Text] [Related]
2. Review: Immune-Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer.
Suarez-Almazor ME; Kim ST; Abdel-Wahab N; Diab A
Arthritis Rheumatol; 2017 Apr; 69(4):687-699. PubMed ID: 28085999
[No Abstract] [Full Text] [Related]
3. Adverse and unconventional reactions related to immune checkpoint inhibitor therapy for cancer.
Li N; Wang G; Hou X; Tai R; Huang S; He Z; Lei L; Xu S; Yang S
Int Immunopharmacol; 2022 Jul; 108():108803. PubMed ID: 35569432
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of immune-related adverse events during the treatment of cancer with immune checkpoint inhibitors.
Weinmann SC; Pisetsky DS
Rheumatology (Oxford); 2019 Dec; 58(Suppl 7):vii59-vii67. PubMed ID: 31816080
[TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint inhibitors: a narrative review of considerations for the anaesthesiologist.
Lewis AL; Chaft J; Girotra M; Fischer GW
Br J Anaesth; 2020 Mar; 124(3):251-260. PubMed ID: 32007241
[TBL] [Abstract][Full Text] [Related]
6. Atypical autoimmune adverse effects with checkpoint blockade therapies.
Friedman CF; Snyder A
Ann Oncol; 2017 Feb; 28(2):206-207. PubMed ID: 27993802
[No Abstract] [Full Text] [Related]
7. Dermatologic Reactions to Immune Checkpoint Inhibitors : Skin Toxicities and Immunotherapy.
Sibaud V
Am J Clin Dermatol; 2018 Jun; 19(3):345-361. PubMed ID: 29256113
[TBL] [Abstract][Full Text] [Related]
8. [Toxicity of immune checkpoints inhibitors].
Delaunay M; Caron P; Sibaud V; Godillot C; Collot S; Milia J; Prévot G; Mazières J
Rev Mal Respir; 2018 Dec; 35(10):1028-1038. PubMed ID: 30213624
[TBL] [Abstract][Full Text] [Related]
9. Liver Toxicity with Cancer Checkpoint Inhibitor Therapy.
Nadeau BA; Fecher LA; Owens SR; Razumilava N
Semin Liver Dis; 2018 Nov; 38(4):366-378. PubMed ID: 30357774
[TBL] [Abstract][Full Text] [Related]
10. Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know.
Braschi-Amirfarzan M; Tirumani SH; Hodi FS; Nishino M
Korean J Radiol; 2017; 18(1):42-53. PubMed ID: 28096717
[TBL] [Abstract][Full Text] [Related]
11. Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.
De Martin E; Michot JM; Papouin B; Champiat S; Mateus C; Lambotte O; Roche B; Antonini TM; Coilly A; Laghouati S; Robert C; Marabelle A; Guettier C; Samuel D
J Hepatol; 2018 Jun; 68(6):1181-1190. PubMed ID: 29427729
[TBL] [Abstract][Full Text] [Related]
12. [Management of toxicities from immunotherapy].
Heinrich K; von Bergwelt-Baildon M; Theurich S
Dtsch Med Wochenschr; 2021 Sep; 146(17):1119-1128. PubMed ID: 34448188
[TBL] [Abstract][Full Text] [Related]
13. Setting the scene - a future 'epidemic' of immune-related adverse events in association with checkpoint inhibitor therapy.
Bermudez MV; Papa S
Rheumatology (Oxford); 2019 Dec; 58(Suppl 7):vii1-vii6. PubMed ID: 31816083
[TBL] [Abstract][Full Text] [Related]
14. A review of the imaging manifestations of immune check point inhibitor toxicities.
Thomas R; Sebastian B; George T; Majeed NF; Akinola T; Laferriere SL; Braschi-Amirfarzan M
Clin Imaging; 2020 Aug; 64():70-79. PubMed ID: 32334270
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Summarized Overview.
Plachouri KM; Vryzaki E; Georgiou S
Curr Drug Saf; 2019; 14(1):14-20. PubMed ID: 30058498
[TBL] [Abstract][Full Text] [Related]
16. Immune Checkpoint Inhibitor Cancer Therapy: Spectrum of Imaging Findings.
Wang GX; Kurra V; Gainor JF; Sullivan RJ; Flaherty KT; Lee SI; Fintelmann FJ
Radiographics; 2017; 37(7):2132-2144. PubMed ID: 29131763
[TBL] [Abstract][Full Text] [Related]
17. Immune checkpoint inhibitors and endocrine side effects, a narrative review.
Agrawal L; Bacal A; Jain S; Singh V; Emanuele N; Emanuele M; Meah F
Postgrad Med; 2020 Mar; 132(2):206-214. PubMed ID: 31876444
[TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Inhibitor Toxicity in 2018.
Johnson DB; Chandra S; Sosman JA
JAMA; 2018 Oct; 320(16):1702-1703. PubMed ID: 30286224
[No Abstract] [Full Text] [Related]
19. Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.
Postow MA; Sidlow R; Hellmann MD
N Engl J Med; 2018 Jan; 378(2):158-168. PubMed ID: 29320654
[No Abstract] [Full Text] [Related]
20. Cancer immunotherapy-associated hypophysitis.
Castillero F; Castillo-Fernández O; Jiménez-Jiménez G; Fallas-Ramírez J; Peralta-Álvarez MP; Arrieta O
Future Oncol; 2019 Sep; 15(27):3159-3169. PubMed ID: 31423850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]